International Stem Cell (ISCO) Operating Expenses (2010 - 2026)

International Stem Cell (ISCO) has reported Operating Expenses for 17 consecutive years, with $2.7 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Operating Expenses rose 18.86% year-over-year to $2.7 million in Q2 2026; TTM through Jun 2026 was $9.7 million, a 4.79% increase from a year earlier, with the FY2025 full-year figure at $9.4 million, up 2.34% from the prior year.
• Operating Expenses was $2.7 million for Q2 2026 at International Stem Cell, up from $2.5 million in the prior quarter.
• Over five years, Operating Expenses peaked at $2.7 million in Q2 2026 and troughed at $2.0 million in Q2 2023.
• A 5-year average of $2.2 million and a median of $2.3 million in 2025 frame the typical range for Operating Expenses.
• Across the five-year window, Operating Expenses fell 18.74% in 2022 and climbed 18.86% in 2026, its largest moves.
• Over 5 years, Operating Expenses stood at $2.4 million in 2022, then slipped by 2.36% to $2.3 million in 2023, then climbed by 3.55% to $2.4 million in 2024, then climbed by 3.05% to $2.5 million in 2025, then rose by 9.81% to $2.7 million in 2026.
• The last three Operating Expenses figures came in at $2.7 million (Q2 2026), $2.5 million (Q4 2025), and $2.3 million (Q3 2025), per Business Quant data.